Canada Markets closed

Ampio Pharmaceuticals, Inc. (APH.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.4080-0.0180 (-4.23%)
At close: 03:36PM CET
Currency in EUR

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.49
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.1000
52 Week Low 30.3860
50-Day Moving Average 30.6859
200-Day Moving Average 31.1966

Share Statistics

Avg Vol (3 month) 354
Avg Vol (10 day) 3N/A
Shares Outstanding 5227.13M
Implied Shares Outstanding 6N/A
Float 8188.18M
% Held by Insiders 16.77%
% Held by Institutions 122.75%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec. 31, 2020
Most Recent Quarter (mrq)Sep. 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-50.15%
Return on Equity (ttm)-110.49%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -14.13M
Net Income Avi to Common (ttm)-15.47M
Diluted EPS (ttm)-0.0700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.12M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)998k
Total Debt/Equity (mrq)5.78
Current Ratio (mrq)7.95
Book Value Per Share (mrq)0.09

Cash Flow Statement

Operating Cash Flow (ttm)-13.27M
Levered Free Cash Flow (ttm)-7.39M